The Role of Bioelements in Fibromyalgia: Disease Activity or Depression-Anxiety?
1 other identifier
observational
100
1 country
1
Brief Summary
The aim of this observational study was to determine the levels of serum bioelements in patients with fibromyalgia syndrome and to evaluate the relationship of these bioelements with disease activity, depression and anxiety. primary hypothesis: Are serum bioelement levels of women with fibromyalgia syndrome different from healthy people? secondary hypothesis: Are serum bioelement levels associated with disease activity? Are serum bioelement levels associated with depression and anxiety?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2016
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2017
CompletedFirst Submitted
Initial submission to the registry
March 28, 2026
CompletedFirst Posted
Study publicly available on registry
April 9, 2026
CompletedApril 9, 2026
April 1, 2026
3 months
March 28, 2026
April 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Fibromyalgia Impact Questionnaire (FIQ).
The FIQ was developed to measure functional status in patients with FMS, and its validity and reliability in the Turkish population were determined by Sarmer et al. The total score ranges from 0 to 100, with a higher score indicating greater disease impact.
Baseline
Secondary Outcomes (3)
Visual Analog Scale (VAS)
Baseline
Hospital Anxiety and Depression Scale (HAD)
Baseline
Nottingham Health Profile (NHP)
Baseline
Study Arms (2)
fibromyalgia group
After applying the exclusion criteria, with expert diagnosis considered as the gold standard, 50 patients were selected who were diagnosed with FMS according to the 2010 FMS diagnostic criteria of the American Rheumatology College (14) with symptoms for at least 3 months, widespread pain index (WPI) ≥ 7 and symptom severity (SS) scale score ≥ 5 or WPI 3-6 and SS scale score ≥ 9.
control group
The control group consisted of individuals with a similar age distribution, no history of chronic pain, and who did not meet the exclusion criteria
Interventions
Selenium, magnesium, iron, copper, manganese and zinc levels
Eligibility Criteria
After applying the exclusion criteria, with expert diagnosis considered as the gold standard, 50 patients were selected who were diagnosed with FMS according to the 2010 FMS diagnostic criteria of the American Rheumatology College (14) with symptoms for at least 3 months, widespread pain index (WPI) ≥ 7 and symptom severity (SS) scale score ≥ 5 or WPI 3-6 and SS scale score ≥ 9.
You may qualify if:
- Mentally competent
- Women over the age of 18
You may not qualify if:
- Over 65 years of age
- Pregnancy
- Systemic inflammatory rheumatic disease
- Socioculturally uncommunicative individuals
- Infection
- Malignancy
- Fracture
- Coagulopathy
- Peripheral circulatory disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ankara City Hospital Bilkentlead
- Firat Universitycollaborator
Study Sites (1)
Fırat University Faculty of Medicine
Elâzığ, Centre, 23119, Turkey (Türkiye)
Related Publications (14)
Aydemir O. Hastane anksiyete ve depresyon olcegi Turkce formunun gecerlilik ve guvenilirligi. Turk Psikiyatri Derg. 1997;8:187-280.
RESULTAksu S, Aslikurne, Düger T, Öksüz Ç, Cezmitürk, Gedizoğlu T, et al. Are results of the SF-36 health survey and the Nottingham health profile similar in migraine patients? The Pain Clinic. 2004;16(2):167-71.
RESULTKucukdeveci AA, McKenna SP, Kutlay S, Gursel Y, Whalley D, Arasil T. The development and psychometric assessment of the Turkish version of the Nottingham Health Profile. Int J Rehabil Res. 2000 Mar;23(1):31-8. doi: 10.1097/00004356-200023010-00004.
PMID: 10826123RESULTSarmer S, Ergin S, Yavuzer G. The validity and reliability of the Turkish version of the Fibromyalgia Impact Questionnaire. Rheumatol Int. 2000 Dec;20(1):9-12. doi: 10.1007/s002960000077.
PMID: 11149662RESULTPrice DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain. 1983 Sep;17(1):45-56. doi: 10.1016/0304-3959(83)90126-4.
PMID: 6226917RESULTWolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis care & research. 2010;62(5):600-10.
RESULTMlyniec K, Davies CL, de Aguero Sanchez IG, Pytka K, Budziszewska B, Nowak G. Essential elements in depression and anxiety. Part I. Pharmacol Rep. 2014 Aug;66(4):534-44. doi: 10.1016/j.pharep.2014.03.001. Epub 2014 Apr 2.
PMID: 24948052RESULTSerefko A, Szopa A, Poleszak E. Magnesium and depression. Magnes Res. 2016 Mar 1;29(3):112-119. doi: 10.1684/mrh.2016.0407.
PMID: 27910808RESULTKim YS, Kim KM, Lee DJ, Kim BT, Park SB, Cho DY, Suh CH, Kim HA, Park RW, Joo NS. Women with fibromyalgia have lower levels of calcium, magnesium, iron and manganese in hair mineral analysis. J Korean Med Sci. 2011 Oct;26(10):1253-7. doi: 10.3346/jkms.2011.26.10.1253. Epub 2011 Oct 1.
PMID: 22022174RESULTPickering G, Mazur A, Trousselard M, Bienkowski P, Yaltsewa N, Amessou M, Noah L, Pouteau E. Magnesium Status and Stress: The Vicious Circle Concept Revisited. Nutrients. 2020 Nov 28;12(12):3672. doi: 10.3390/nu12123672.
PMID: 33260549RESULTSendur OF, Tastaban E, Turan Y, Ulman C. The relationship between serum trace element levels and clinical parameters in patients with fibromyalgia. Rheumatol Int. 2008 Sep;28(11):1117-21. doi: 10.1007/s00296-008-0593-9. Epub 2008 May 22.
PMID: 18496697RESULTOzgocmen S, Ozyurt H, Sogut S, Akyol O. Current concepts in the pathophysiology of fibromyalgia: the potential role of oxidative stress and nitric oxide. Rheumatol Int. 2006 May;26(7):585-97. doi: 10.1007/s00296-005-0078-z. Epub 2005 Nov 20.
PMID: 16328420RESULTJurado-Priego LN, Cueto-Urena C, Ramirez-Exposito MJ, Martinez-Martos JM. Fibromyalgia: A Review of the Pathophysiological Mechanisms and Multidisciplinary Treatment Strategies. Biomedicines. 2024 Jul 11;12(7):1543. doi: 10.3390/biomedicines12071543.
PMID: 39062116RESULTAlvarez MC, Albuquerque MLL, Neiva HP, Cid L, Rodrigues F, Teixeira DS, Monteiro D. Differences between Portuguese and Brazilian Patients with Fibromyalgia Syndrome: Exploring the Associations across Age, Time of Diagnosis, and Fatigue-Related Symptoms. Medicina (Kaunas). 2021 Apr 1;57(4):322. doi: 10.3390/medicina57040322.
PMID: 33915694RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ayşe u Baykut
Ankara City Hospital Bilkent
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- doctor
Study Record Dates
First Submitted
March 28, 2026
First Posted
April 9, 2026
Study Start
December 1, 2016
Primary Completion
March 1, 2017
Study Completion
April 1, 2017
Last Updated
April 9, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
The study began enrolling participants before January 1, 2019